Similar to RCC-ECFCs, however, the pharmacological inhibition of SOCE abrogated BC-ECFC proliferation and tube formation, thereby confirming that Orai1 and TRPC1 could serve as reliable targets to interfere with tumor vascularization, although this hypothesis remains to be validated in vivo [134,135]. Here, TRPC1 is linked to neoplasm.